14-day Premium Trial Subscription Sign Up For FreeGet Free

$12.02 (-1.23%)

Volume: 824k

Closed: Nov 29, 2021

Hollow Logo Score: 4.114

FibroGen Stock Forecast

$12.02 (-1.23%)

Volume: 824k

Closed: Nov 29, 2021

Score Hollow Logo 4.114
Which way will FGEN go? Request
Stop-loss: $11.32 (-5.83%)
Key Stats
P/E Ratio -5.19
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 49 and the stock is currently not being overbought or oversold

Red day on Monday for FibroGen stock after losing 1.23%
(Updated on Nov 29, 2021)

Buy or Hold candidate since 2021-11-16 Loss -4.45%

The FibroGen stock price fell by -1.23% on the last day (Monday, 29th Nov 2021) from $12.17 to $12.02. and has now fallen 3 days in a row. During the day the stock fluctuated 5.36% from a day low at $11.93 to a day high of $12.57. The price has fallen in 6 of the last 10 days and is down by -0.25% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -59 thousand shares and in total, 824 thousand shares were bought and sold for approximately $9.91 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.25% during the next 3 months and, with a 90% probability hold a price between $11.25 and $14.33 at the end of this 3-month period.

Signals & Forecast

The FibroGen stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $12.27. On a fall, the stock will find some support from the long-term average at approximately $11.69. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Monday, November 22, 2021, and so far it has risen 0.59%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

FibroGen finds support from accumulated volume at $11.69 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.64 between high and low, or 5.36%. For the last week, the stock has had a daily average volatility of 6.61%.

Our recommended stop-loss: $11.32 (-5.83%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Is FibroGen stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for FibroGen stock to perform well in the short-term.

Current score: 4.114

Predicted Opening Price for FibroGen of Tuesday, November 30, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 30, 2021 Current price
$12.17 $12.02 (Undervalued)
Buy Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Sep 22, 2021 "The Goldman Sachs Group" gave "$16.00 - $11.00" rating for FGEN. The price target was changed from $11.24 to 0.3%.

Volatility and Risk
Daily Average Volatility: 6.61 %
Overall Risk: Very High High Medium Low Very Low
6.61 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $12.21
Price: $12.02
Support: $11.69

FGEN Insider Trading Show all Trades



Last 100 transactions
Buy: 1 254 356 | Sell: 232 467 (Shares)
Date Action Amount Person Type
Oct 06, 2021 Sell 1 859 Conterno Enrique A Common Stock
Oct 04, 2021 Buy 32 360 Chung Christine Stock Option (Right to Buy)
Oct 04, 2021 Buy 54 170 Chung Christine Common Stock
Oct 04, 2021 Buy 44 520 Eisner Mark Stock Option (Right to Buy)
Oct 04, 2021 Buy 74 520 Eisner Mark Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 1 254 356 | Sell: 232 467 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 12.81 6.60 %
12.57 4.57 %
12.42 3.31 %
Current price: 12.02
Support 11.93 -0.76 %
11.78 -2.01 %
11.53 -4.05 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 12.41 3.24 %
12.39 3.08 %
12.21 1.58 %
Current price 12.02
Support 11.69 -2.75%
11.04 -8.15%
10.18 -15.31%

Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. It is developing roxadustat, or FG-4592, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; FG-3019, a monoclonal antibody in Phase II clinical development ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE